Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib
(Q46735182)
scientific article
scientific article
Language:
Current Data About
Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib
other details